Viewing Study NCT04248569


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2025-12-24 @ 11:04 PM
Study NCT ID: NCT04248569
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2020-01-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module